Brief: Bioarctic AB Says Leqembi® Q3 2023 Sales 0.4 Billion Yen
07/11/2023 03:44
Nov 6 (Reuters) - BioArctic AB BIOAb.ST :
* : LEQEMBI® Q3 2023 SALES PUBLISHED - 0.4 BILLION YEN
RECORDED IN
PERIOD
* LEQEMBI SALES FOR Q3 2023 WERE 0.4 BILLION YEN RESULTING
IN A
ROYALTY TO BIOARCTIC AMOUNTING TO SEK 2.5 MILLION
Source text for Eikon: ID:nWkr6D2S3V
Further company coverage: BIOAb.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioArctic AB
See all newsBrief: BioArctic And Lilly Sign Research, Collaboration Agreement
Brief: Bioarctic AB Declares Dividend Of Sek 2 Per Share With 1 June 2026 Record Date
Brief: Bioarctic Partner Eisai Presents Leqembi Sales Simulation
Sweden's BioArctic Q1 revenue drops sharply despite higher Leqembi royalties
Brief: BioArctic Q1 Operating Profit SEK 210.8 Million